Modeling of second-order spectrophotometric data generated by a pH-gradient flow injection technique for the determination of doxorubicin in human plasma

Microchemical Journal

Volumn 112, Issue , 2014, Pages 25-33

  Alcaráz, Mirta R ^a   Schenone, Agustina V ^a   Culzoni, María J ^a   Goicoechea, Héctor C ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Doxorubicin; Human plasma; Multivariate curve resolution; Second order calibration

Indexed keywords

EID: 84885369042     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2013.09.012     Document Type: Article

References (34)

1. Speth P.A., van Hoesel Q.G., Haanen C. Clinical pharmacokinetics of doxorubicin. Clin. Pharmacokinet. 1988, 15:15-31.
2. Benjamin R.S., Jr Riggs C.E., Bachur N.R. Pharmacokinetics and metabolism of adriamycin in man. Clin. Pharmacol. Ther. 1973, 14:592-600.
3. Licata S., Saponiero A., Mordente A., Minotti G. Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction. Chem. Res. Toxicol. 2000, 13:414-420.
4. DeVita V.T., Rosenberg S.A., Hellman S. Cancer, Principles and Practice of Oncology 2001, Lippincott, Williams & Wilkins, Philadelphia.
5. Andersen A., Warren D.J., Slordal L. A sensitive and simple high-performance liquid chromatographic method for determination of doxorubicin and its metabolites in plasma. Ther. Drug Monit. 1993, 15:455-461.
6. Gotlieb W.H., Bruchim I., Ben-Baruch G., Davidson B., Zeltser A., Andersen A., Olsen H. Doxorubicin levels in the serum and ascites of patients with ovarian cancer. EJSO 2007, 33:213-215.
7. Chen C.L., Thoen K.K., Uckun F.M. High-performance liquid chromatographic methods for the determination of topoisomerase II inhibitors. J. Chromatogr. B Biomed. Appl. 2001, 764:81-119.
8. Loadman P.M., Calabrese C.R. Separation methods for anthraquinone related anti-cancer drugs. J. Chromatogr. B Biomed. Appl. 2001, 764:193-206.
9. Fahmy O.T., Korany M.A., Maher H.M. High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma. J. Pharm. Biomed. Anal. 2004, 34:1099-1107.
10. DiFrancesco R., Griggs J.J., Donnelly J., DiCenzo R. Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 2007, 852:545-553.
11. Lachâtre F., Marquet P., Ragot S., Gaulier J.M., Cardot P., Dupuy J.L. Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B 2000, 738:281-291.
12. Zagotto G., Gatto B., Moro S., Sissi C., Palumbo M. Anthracyclines: recent developments in their separation and quantitation. J. Chromatogr. B Biomed. Appl. 2001, 764:161-171.
13. Lu H., Yuan G., He Q., Chen H. Rapid analysis of anthracycline antibiotics doxorubicin and daunorubicin by microchip capillary electrophoresis. Microchem. J. 2009, 92:170-173.
14. Saurina J., Hernández-Cassou S. Quantitative determinations in conventional flow injection analysis based on different chemometric calibration strategies: a review. Anal. Chim. Acta 2000, 438:335-352.
15. Karlberg B., Torgrip R. Increasing the scope and power of flow-injection analysis through chemometric approaches. Anal. Chim. Acta 2003, 500:299-306.
16. Culzoni M.J., Goicoechea H.C. Determination of loratadine and pseudoephedrine sulfate in pharmaceuticals based on non-linear second order spectrophotometric data generated by a pH-gradient flow injection technique and artificial neural networks. Anal. Bioanal. Chem. 2007, 389:2217-2225.
17. Saurina J., Hernández-Cassou S., Izquierdo-Ridorsa A., Tauler R. pH-Gradient spectrophotometric data files from flow-injection and continuous flow systems for two- and three-way data analysis. Chemom. Intell. Lab. Syst. 2000, 50:263-271.
18. Marsili N.R., Lista A., Fernández Band B.S., Goicoechea H.C., Olivieri A.C. A new method for the determination of benzoic and sorbic acids in commercial orange juices based on second-order spectrophotometric data generated by a pH gradient flow injection technique. J. Agric. Food Chem. 2004, 52:2479-2484.
19. Marsili N.R., Lista A., Fernandez Band B.S., Goicoechea H.C., Olivieri A.C. Evaluation of complex spectral-ph three-way arrays by modified bilinear least-squares: determination of four different dyes in interfering systems. Analyst 2005, 130:1291-1298.
20. Saurina J. Flow-injection analysis for multi-component determinations of drugs based on chemometric approaches. TrAC Trends Anal. Chem. 2010, 29:1027-1037.
21. Escandar G.M., Faber N.M., Goicoechea H.C., Muñoz de la Peña A., Olivieri A.C., Poppi R.J. Second and third-order multivariate calibration: data, algorithms and applications. TrAC Trends Anal. Chem. 2007, 26:752-765.
22. Trevisan M.G., Poppi R.J. Determination of doxorubicin in human plasma by excitation-emission matrix fluorescence and multi-way analysis. Anal. Chim. Acta 2003, 493:69-81.
23. Schenone A.V., Culzoni M.J., Campiglia A.D., Goicoechea H.C. Total synchronous fluorescence spectroscopic data modeled with first- and second-order algorithms for the determination of doxorubicin in human plasma. Anal. Bioanal. Chem. 2013, (in press). 10.1007/s00216-013-7261-y.
24. Avdeef A. Absorption and Drug Development: Solubility, Permeability, and Charge State 2012, Wiley, New York. Second ed.
25. MATLAB 7.10 The MathWorks Inc., Natick, Massachusetts, USA 2010.
26. Ibañez G.A., Escandar G.M., Olivieri A.C. Formation constants of copper(II)-salicylic acid complexes from multi-wavelength spectrophotometric pH titration data analyzed by alternating least-squares including Newton-Raphson and Gauss-Newton procedures. Chem. Educ. 2007, 12:22-28.
27. Winding W., Guilment J. Interactive self-modeling mixture analysis. Anal. Chem. 1991, 63:1425-1432.
28. Saurina J., Hernández-Cassou S., Tauler R., Izquierdo-Ridorsa A. Spectrophotometric determination of pK(a) values based on a pH gradient flow-injection system. Anal. Chim. Acta 2000, 408:135-143.
29. Abraham S.A., Waterhouse D.N., Mayer L.D., Cullis P.R., Madden T.D., Bally M.B. The liposomal formulation of doxorubicin. Method Enzymol. 2005, 391:71-97.
30. Bauza M.C., Ibañez G.A., Tauler R., Olivieri A.C. Sensitivity equation for quantitative analysis with multivariate curve resolution-alternating least-squares: theoretical and experimental approach. Anal. Chem. 2012, 84:8697-8706.
31. (European Medicines Agency, accessed May 2013). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
32. Sosa M., Széliga M.E., Fernández A., Bregni C. Rifampicin and bioavailability in combination formulation. ARS Pharm. 2005, 46:353-364.
33. Riu J., Rius F.X. Method comparison using regression with uncertainties in both axes. Trends Anal. Chem. 1997, 16:211-216.
34. Alvarez-Cedron L., Sayalero M.L., Lanao J.M. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues. J. Chromatogr. B 1999, 721:271-278.